Famotidine mechanism of action
Pro Research Analysisby 
Searched over 200M research papers
Famotidine Mechanism of Action: Histamine H2 Receptor Antagonism
Famotidine is primarily known as a histamine H2 receptor antagonist. By blocking H2 receptors, especially in the stomach’s parietal cells, famotidine reduces gastric acid secretion, which is its main use in treating conditions like gastroesophageal reflux disease and peptic ulcers 29. This H2 receptor antagonism also extends to immune cells such as neutrophils and eosinophils, where it can inhibit the release of pro-inflammatory cytokines 29.
Anti-Inflammatory Effects and the Vagus Nerve
Recent research has uncovered that famotidine’s anti-inflammatory effects are not solely due to H2 receptor antagonism. Famotidine can activate the body’s inflammatory reflex, a mechanism involving the vagus nerve and the alpha 7 nicotinic acetylcholine receptor (α7nAChR), which helps suppress excessive inflammation. This effect is independent of mast cells and is more pronounced when famotidine is administered directly into the central nervous system, suggesting a central nervous system mechanism 13. The anti-inflammatory action is abolished if the vagus nerve is severed or if α7nAChR is genetically knocked out, confirming the importance of this pathway 13.
Potential Antiviral and Host-Mediated Mechanisms
While computational studies have suggested that famotidine might inhibit viral proteases involved in SARS-CoV-2 replication, there is no strong evidence for direct antiviral activity in living systems. Instead, its benefits in COVID-19 are thought to be due to its effects on histamine signaling and inflammation, rather than direct action against the virus 29.
Inhibition of Carbonic Anhydrase Enzymes
Famotidine also acts as a potent inhibitor of several human and bacterial carbonic anhydrase enzymes. This action is unrelated to its H2 receptor antagonism and may contribute to its antibacterial properties, particularly against Helicobacter pylori, but is not central to its main clinical uses 45.
Modulation of Cell Signaling and Neuroprotection
Famotidine has been shown to increase cellular phospho-tyrosine levels, which can affect cell signaling pathways and potentially enhance the antiviral state of cells . Additionally, famotidine can inhibit glycogen synthase kinase-3β (GSK-3β), a key enzyme involved in neurodegenerative diseases and psychiatric disorders. This inhibition may underlie observed neuroprotective effects in models of Alzheimer’s disease and schizophrenia, suggesting possible benefits beyond its traditional uses 710.
Pro-Inflammatory Effects in Specific Contexts
In some settings, such as in gastric cancer cells, famotidine has been found to promote inflammation by triggering cell pyroptosis, a form of programmed cell death associated with the release of inflammatory factors. This effect involves activation of the NLRP3 inflammasome and increased secretion of interleukin-18, highlighting that famotidine’s effects can vary depending on the biological context .
Conclusion
Famotidine’s primary mechanism of action is the blockade of histamine H2 receptors, leading to reduced gastric acid secretion and modulation of immune responses. It also exerts anti-inflammatory effects through activation of the vagus nerve inflammatory reflex and can inhibit carbonic anhydrase enzymes. In certain contexts, famotidine can influence cell signaling and provide neuroprotection, while in others, it may promote inflammation. These diverse mechanisms make famotidine a drug of interest for repurposing in various clinical scenarios, including inflammatory and neurodegenerative diseases.
Sources and full results
Most relevant research papers on this topic